IL-10 Gene Polymorphisms and Self-Medication With Over-the-Counter Nonsteroidal Anti-Inflammatory Drugs

Abstract

Background:

Genetic influences on self-medication with over-the-counter (OTC) drugs merit investigation. For example, patients frequently use OTC nonsteroidal anti-inflammatory drugs (NSAIDs) to treat inflammation, but the inflammatory response is also affected by endogenous cytokines whose production varies across polymorphisms of their encoding genes. In the case of interleukin 10 (IL-10), literature suggests that a single nucleotide polymorphism (SNP) in the promoter region of the cytokine’s gene (-1082 A > G [rs1800896]) influences production with higher levels associated with G variant alleles.

Objective:

To demonstrate the feasibility of researching the role of genetics in self-medication by using existing national survey data to evaluate a possible association between OTC NSAID use and genotype at the -1082 SNP of the IL-10 gene.

Methods:

Statistical analyses were performed using data from 6,309 participants in the Third National Health and Nutrition Examination Survey (NHANES III).

Results:

OTC NSAID use (aspirin or ibuprofen) in the previous month was significantly more common among persons with AG or GG genotypes at the -1082 SNP. Odds of use consistently increased relative to the number of G alleles. This trend remained statistically significant (odds ratio = 1.14 per additional G allele, p = .02, 95% confidence interval [1.02, 1.27]) after adjustment for confounding.

Conclusions:

Analysis of population-based genetic data suggests an association between a common self-medication behavior and a specific genetic polymorphism. These findings broadly demonstrate that NHANES data provide opportunities to investigate such associations and specifically imply that potential interrelationships among OTC NSAID use, IL-10 genotype, and IL-10 cytokine levels deserve further study.

Keywords

cytokine inflammation genetics NSAID self-medication NHANES III

Get full access to this article

View all access options for this article.

References

Andersen

Vogel

(2014). Systemic review: Interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancer. Alimentary Pharmacology and Therapeutics, 40, 147–159. doi:10.1111/apt.12807

Balding

D. J.

(2006). A tutorial on statistical methods for population association studies. Nature Reviews Genetics, 7, 781–791. doi:10.1038/nrg1916

Breslow

N. E.

Day

N. E.

(1980). Statistical methods in cancer research. Volume I—The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer.

Centers for Disease Control and Prevention. (2014a). Research Data Center: NCHS Research Data Center (RDC). Retrieved from http://www.cdc.gov/rdc/

Centers for Disease Control and Prevention. (2014b). Research Data Center: Remote access. Retrieved from http://www.cdc.gov/rdc/b2accessmod/acs230.htm

Chang

Lindegren

M. L.

Butler

M. A.

Chanock

S. J.

Dowling

N. F.

Gallagher

… Khoury

M. F.

(2009). Prevalence in the United Stated of selected candidate gene variants, Third National Health and Nutrition Examination Survey, 1991–1994. American Journal of Epidemiology, 169, 54–66. doi:10.1093/aje/kwn286

Clarke

G. M.

Anderson

C. A.

Pettersson

F. H.

Cardon

L. R.

Morris

A. P.

Zondervan

K. T.

(2011). Basic statistical analysis in genetic case-control studies. Nature Protocols, 6, 121–133. doi:10.1038/nprot.2010.182

Crawford

D. C.

Nickerson

D. A.

(2005). Definition and clinical importance of haplotypes. Annual Review of Medicine, 56, 303–320. doi:10.1146/annurev.med.56.082103.104540

Crawley

Kay

Sillibourne

Patel

Hutchinson

Woo

(1999). Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis and Rheumatism, 42, 1101–1108.

10.

DeBolle

Mehuys

Adriaens

Remon

J. P.

Van Bortel

Christiaens

(2008). Home medication cabinets and self-medication: A source of potential health threats? Annals of Pharmacotherapy, 42, 572–579. doi:10.1345/aph.1K533

11.

Eskdale

Gallagher

Verweij

C. L.

Keijsers

Westendorp

R. G. J.

Huizinga

T. W. J.

(1998). Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proceedings of the National Academy of Sciences of the U S A, 95, 9465–9470.

12.

Food and Drug Administration. Center for Drug Evaluation and Research. (1999, 10 12). Consult—Over the counter nonsteroidal anti-inflammatory drugs (NSAIDS), renal failure at OTC dosing levels [Memorandum]. Retrieved from http://www.fda.gov/ohrms/dockets/ac/02/briefing/3882b1_03_B-NSAID%20Renal%20Review.pdf

13.

Freedman

D. A.

(1983). A note on screening regression equations. American Statistician, 37, 152–155. doi:10.1080/00031305.1983.10482729

14.

Hyun

M.-H.

Lee

C.-H.

Kang

M.-H.

Park

B.-K.

Lee

Y. H.

(2013). Interleukin-10 promoter gene polymorphisms and susceptibility to asthma: A meta-analysis. PLoS One, 8, e53758. doi:10.1371/journal.pone.0053758

15.

Jurek

A. M.

Greenland

Maldonado

Church

T. R.

(2005). Proper interpretation of non-differential misclassification effects: Expectations vs observations. International Journal of Epidemiology, 34, 680–687. doi:10.1093/ije/dyi060

16.

Kaufman

D. W.

Kelly

J. P.

Rosenberg

Anderson

T. E.

Mitchell

A. A.

(2002). Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. Journal of the American Medical Association, 287, 337–344. doi:10.1001/jama.287.3.337

17.

Kim

J. M.

Brannan

C. I.

Copeland

N. G.

Jenkins

N. A.

Khan

T. A.

Moore

K. W.

(1992). Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. Journal of Immunology, 148, 3618–3623.

18.

Kleinbaum

D. G.

Kupper

L. L.

Morgenstern

(1982). Epidemiologic research: Principles and quantitative methods. New York, NY: Van Nostrand Reinhold Company.

19.

Korn

E. L.

Graubard

B. I.

(1999). Analysis of health surveys. New York, NY: John Wiley.

20.

Koss

Satsangi

Fanning

G. C.

Welsh

K. I.

Jewell

D. P.

(2000). Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: Differential effects on production and allele frequencies. Genes and Immunity, 1, 185–190.

21.

Lalani

Bhol

Ahmed

A. R.

(1997). Interleukin-10: Biology, role in inflammation and autoimmunity. Annals of Allergy, Asthma, and Immunology, 79, 469–484.

22.

Lee

Y. H.

Bai

S. C.

Choi

S. J.

Song

G. G.

(2012). Associations between interleukin-10 polymorphism and susceptibility to rheumatoid arthritis: A meta-analysis. Molecular Biology Reports, 39, 81–87. doi:10.1007/s11033-011-0712-7

23.

Lee

Y. H.

Choi

S. J.

J. D.

Song

G. G.

(2012). Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: A meta-analysis. Inflammation Research, 61, 657–663. doi:10.1007/s0011-012-0458-2

24.

Moonesinghe

Yesupriya

Chang

Dowling

N. F.

Khoury

M. J.

Scott

A. J.

(2010). A Hardy–Weinberg equilibrium test for analyzing population genetic surveys with complex sample designs. American Journal of Epidemiology, 171, 932–941. doi:10.1093/aje/kwq002

25.

Mosser

D. M.

Zhang

(2008). Interleukin-10: New perspectives on an old cytokine. Immunology Review, 226, 205–218. doi:10.1111/j.1600-065X.2008.00706.x

26.

National Center for Biotechnology Information. (2014). RefSeqGene: IL10—Interleukin 10. Retrieved from http://www.ncbi.nlm.nih.gov/gene/3586

27.

National Center for Health Statistics. (1996). Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994, NHANES III adult data file documentation (Catalog no. 77560). Hyattsville, MD: Centers for Disease Control and Prevention.

28.

National Center for Health Statistics. (1998). Third National Health and Nutrition Examination Survey (NHANES III), 1988-94, NHANES III partial household adult data file documentation, vitamin, mineral and medicine usage (Series 11, no. 2A). Hyattsville, MD: Centers for Disease Control and Prevention.

29.

National Center for Health Statistics. (2013a). National Health and Nutrition Examination Survey: Collection of DNA. Retrieved from http://www.cdc.gov/nchs/nhanes/genetics/collection_dna.htm

30.

National Center for Health Statistics. (2013b). National Health and Nutrition Examination Survey: How to access genetic data sets. Retrieved from http://www.cdc.gov/nchs/nhanes/genetics/genetic_access.htm#restricted

31.

National Center for Health Statistics. (2014). National Health and Nutrition Examination Survey: NHANES III. Retrieved from http://www.cdc.gov/nchs/nhanes/nh3data.htm

32.

National Center for Health Statistics. (2015). National Health and Nutrition Examination Survey biospecimen program: DNA specimens and genetic data. Retrieved from http://www.cdc.gov/nchs/nhanes/biospecimens/dnaspecimens.htm

33.

Niu

(2004). Algorithms for inferring haplotypes. Genetic Epidemiology, 27, 334–347. doi:10.1002/gepi.20024

34.

Olmos

D. R.

(1994, 6 17). Release of new pain reliever spurs analgesics marketing war: Pharmaceuticals: Syntex Corp.’s Aleve could hasten a shakeout in the crowded $2.4-billion industry. Los Angeles Times. Retrieved from http://articles.latimes.com/1994-06-17/business/fi-5352_1_prescription-pain-reliever

35.

Paulose-Ram

Hirsch

Dillon

(2005). Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults. Pharmacoepidemiology and Drug Safety, 14, 257–266.

36.

Paulose-Ram

Hirsch

Dillon

Losonczy

Cooper

Ostchega

(2003). Prescription and non-prescription analgesic use among the US adult population: Results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiology and Drug Safety, 12, 315–326.

37.

Qin

Wang

Liang

Yang

Zhong

(2013). The association between TNF-α, Il-10 gene polymorphisms and primary Sjögren’s syndrome: A meta-analysis and systemic review. PLoS One, 8, e63401. doi:10.1371/journal.pone.0063401

38.

Rad

Dossumbekova

Neu

Lang

Bauer

Saur

… Prinz

(2004). Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonization during Helicobacter pylori infection. Gut, 53, 1082–1089.

39.

Rao

J. N. K.

Scott

A. J.

(1987). On simple adjustments to chi-square tests with sample survey data. Annals of Statistics, 15, 385–397.

40.

Roses

A. D.

(2000). Pharmacogenetics and the practice of medicine. Nature, 405, 857–865.

41.

Thomas

D. C.

Witte

J. S.

(2002). Point: Population stratification: A problem for case-control studies of candidate-gene associations. Cancer Epidemiology, Biomarkers, & Prevention, 11, 505–512.

42.

Tian

Gregersen

P. K.

Seldin

M. F.

(2008). Accounting for ancestry: Population substructure and genome-wide association studies. Human Molecular Genetics, 17, R143–R150. doi:10.1093/hmg/ddn268

43.

Tilg

van Montfrans

van den Ende

Kaser

van Deventer

S. J. H.

Schreiber

… Weiss

(2002). Treatment of Crohn’s disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon γ. Gut, 50, 191–195. doi:10.1136/gut.50.2.191

44.

Turner

D. M.

Williams

D. M.

Sankaran

Lazarus

Sinnott

P. J.

Hutchinson

I. V.

(1997). An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 1–8.

45.

Wang

Zhu

J.-M.

Fan

Y.-G.

Wang-Dong

Cen

Pan

H.-F.

D.-Q.

(2013). Association of the -1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis. Gene, 519, 209–216. doi:10.1016/j.gene.2013.01.026

46.

Wang

Ding

Shi

Cao

Qin

Zhu

… Yin

(2012). The interleukin-10 -1082 promoter polymorphism and cancer risk: A meta-analysis. Mutagenesis, 27, 305–312. doi:10.1093/mutage/ger078

47.

Wyatt

J. E.

Pettit

W. L.

Harirforouseh

(2012). Pharmacogenetics of nonsteroidal anti-inflammatory drugs. Pharmacogenomics Journal, 12, 462–467. doi:10.1038/tpj.2012.40

48.

Zhang

Wang

Zhang

(2012). The Il-10 promoter haplotype and cancer risk: Evidence from a meta-analysis. Familial Cancer, 11, 313–319. doi:10.1007/s10689-012-9533-7

49.

Zhang

T. C.

Pan

F. M.

Zhang

L. Z.

Gao

Y. F.

Zhang

Z. H.

Gao

… Li

(2011). A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection, 39, 21–27. doi:10.1007/s15010-010-0075-3